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Background: In a previous report, we suggested a prototypal model to describe
patient states in a graded vector-like format based on the modulo groups via the
psychiatric rating scale. In this article, using other simple examples, we provide
additional suggestions to clarify how other clinical data can be treated practically in
line with our proposed model.
Methods: As illustrations of the wider applicability, we treat four cases
commensurate with modulo arithmetic: 1) prescription doses of three medicines
(lithium carbonate, mirtazapine, and nitrazepam), 2) changes in laboratory data
(blood concentrations of lithium carbonate, white blood cells, percutaneous oxygen
saturation and systolic blood pressure), 3) the tumor node metastasis (TNM)
classification of malignant tumors applied for esophageal tumors, and 4) the coding
schemes of the International Classification of Diseases (ICD) for selected diseases or
laboratory data. For each case, we present simple examples in the form of product
of states to illustrate these results.
Results: 1) Medications and their changes can be represented as elements of a
modulo group; e.g., group S = {Sj | Sj ∈ Z13×Z4×Z3} can represent the set of all
possible prescription combinations of three specified medicines. Likewise, 2) clinical
values can also be expressed as a modulo group; e.g., group T = {Tj | Tj ∈
Z600×Z50000×Z100×Z300} representing the set of all possible data based on any
number of clinical values and their differences. Also, 3) the TNM classification for
malignant tumors can be treated within a single modulo group C = {Cj | Cj ∈
Z8×Z4×Z2×Z2}, the set of all composable disease states graded in terms of tumor
expansion. Finally, 4) ICD coding schemes provide several examples treatable as a
modulo group D = {Dj | Dj ∈ Z7×Z7× . . .×Z7 (an n-fold product)}, constituting the set
of all possible severities of diseases states and laboratory data within provided tuples.
Conclusions: Despite the limited scope of our methodology, there are grounds
where other clinical quantities (prescription of medicine, laboratory data, TNM
classification of malignant tumors, and ICD coding schemes) can be also treatable
with the same group-theory approach as was suggested for psychiatric disease states
in our previous report.
Keywords: Group theory, Modulo operation, Prescription, Laboratory data, TNM
classification, ICD coding schemes© 2012 Sawamura et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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Group theory is one of the cornerstones in various branches of natural science, provid-
ing enormous advantages for their respective fields [1-4]. Unfortunately, medicine has
not been sufficiently systematized in general, and has not attained a level of sophistica-
tion linking it directly with other fields of natural science. One reason for that is the
lack in medical science of a group-theory systematics, in particular, an effective nota-
tional style. Considering these aspects, we have previously suggested a prototypal
model with the potential to describe patient states in a graded vector-like (or Cartesian
product) notation based on the modulo group via the psychiatric rating scale [5].
Briefly, in our previous report, using the BPRS-I (the virtually modified original Brief
Psychiatric Rating Scale that is frequently used for the estimation of psychiatric disease
states), we demonstrated the group-theoretical relationship in the style:
‘AjA j→kð Þ ¼ Aj mod 7ð Þ þ A j→kð Þ mod 7ð Þ ¼ Aj þ A j→kð Þ
 
mod 7ð Þ ¼ Ak mod 7ð Þ’
where j,k = 1,2,3,. . .; (positive integers), Aj denotes a patient’s disease state expressing a
combination of the respective symptom severities, and A(j→k) is an operator that
changes the disease state to Ak by acting, in the group-theory sense, on Aj. Here, the
composition of the operator A(j→k) with the state Aj follows the ‘right translation’ rule,
that is, operators act from the right side of the state.
We presume that this method is also applicable in principle to other psychiatric
evaluation scales such as the ‘Positive and Negative Syndrome Scale’ (PANSS) for
schizophrenia [6], the ‘Montgomery Åsberg Depression Rating Scale (MADRS)’ for de-
pression [7], and almost all psychiatric rating scales so long as an appropriate number
of modulo operations is chosen (as explained in our previous report, prime numbers
are preferred).
In that report, Aj, Ak, and A(j→k) are elements belonging to the same group (Z7
×18, *) and
all possible assessments within the provided psychiatric rating scale; note that to simplify
the discussion, the scoring range, ‘1–7’, of each symptom was modified to ‘0–6’ to treat ele-
ments within a single group based on modulo addition (if not modulo multiplication and
division). A patient’s state is changed only under the operations between the elements
within that group. Not having to use modular operations connecting states of different
patients is one of the advantages of the proposed model; the magnitude of data and/or
handling requirements of patient medical records is considerably reduced.
The focus in the report was restricted in the main to demonstrate handling of psychi-
atric disease states as an example. Only fragmentary suggestions were given for use
with, for example, laboratory data results, the tumor node metastasis (TNM) classifica-
tion of malignant tumors [8], and the International Statistical Classification of Diseases
and Related Health Problems, 10th Revision (ICD-10) [9]. Various aspects were not
investigated sufficiently. In this article, we make redress by providing additional clarifi-
cation on how in practice other clinical data can be treated in line with our proposed
model using other simple examples.
Further demonstrations of the model using clinical values
Applications to prescription dosages and other clinical data
To demonstrate applicability of the proposed model, we use medicine prescription
levels. We assume the following scenario; when we treat a patient with bipolar disorder,
Table 1 An example of prescription dosages for a patient with bipolar disorder
Session 1 Session 2 Session 3 Session 4 Session 5
Lithium carbonate 0 mg/d 200 mg/d 400 mg/d 600 mg/d 300 mg/d
Mirtazapine 0 mg/d 15 mg/d 30 mg/d 45 mg/d 30 mg/d
Nitrazepam 0 mg/d 5 mg/d 10 mg/d 5 mg/d 0 mg/d
Lithium carbonate, mirtazapine, and nitrazepam are prescribed and doses adjusted.
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We suppose the doses for each can be expressed in a vector-like form ‘Sj’ that contains
the dose of lithium in the 1st component, that of mirtazapine in the 2nd component,
and that of nitrazepam in the 3rd component; the vector Sj is denoted S1 = [lithium car-
bonate (mg/d)| mirtazapine (mg/d)| nitrazepam (mg/d)]. For example, S1 of the first
session can be described as: S1 = [0 (mg/d)| 0 (mg/d)| 0 (mg/d)]. In the same manner,
we can consider for the 2nd, 3rd, 4th, and 5th sessions, prescription vectors:
S2 ¼ 200 mg=dð Þ 15 mg=dð Þj j 5 mg=dð Þ½ ;
S3 ¼ 400 mg=dð Þ 30 mg=dð Þj j 10 mg=dð Þ½ ;
S4 ¼ 600 mg=dð Þ 45 mg=dð Þj j 5 mg=dð Þ½ ;
S5 ¼ 300 mg=dð Þ 30 mg=dð Þj j 0 mg=dð Þ½ :
Next, we introduce modulo addition so that the Sj (j = 1,2,. . .,5) have the respectiveoptimized numbers under modulo addition according to the individual restriction on
each component. If supplemented with the modulo divisor ‘xi’ (the number that codes
the modulo operation in i-th component of Sj, i= 1,2,3), then ‘xi’ must be that number
for which ‘xi -1’ multiplied by the unit dose (e.g., ‘100 (mg/d)’ lithium carbonate)
approximates the maximum of its clinical dosage. E.g., the lithium carbonate dosage
would be given over thirteen sessions ‘0 = 0{100}, 100 = 1{100}, 200 = 2{100}, 300 = 3
{100},. . ., 1200 = 12{100}’; thus, the maximum lithium carbonate dosage corresponds to
‘1200 = 100·(x1 - 1)’ giving ‘x1 = 13’, Hence, modulo 13 addition is the operation defined
for the 1st component (lithium carbonate). Likewise for mirtazapine; given the max-
imum dose of 45 (mg/d), we find ‘45 = 15·(x2 - 1)’ yields ‘x2 = 4’, and thus determines
modulo 4 addition for the 2nd component. Similarly, with the maximum of nitrazepam
of 10 mg/d, ‘10 = 5·(x3 - 1)’ gives ‘x3 = 3’, and hence, modulo 3 addition for the 3
rd com-
ponent. We can now rewrite the prescription vectors ‘Sj’s in the form:
S1 ¼ 100 0 mod 13ð Þf g 15 0 mod 4ð Þf gj j 5 0 mod 3ð Þf g½  mg=dð Þ
S2 ¼ 100 2 mod 13ð Þf g 15 1 mod 4ð Þf gj j 5 1 mod 3ð Þf g½  mg=dð Þ
S3 ¼ 100 4 mod 13ð Þf g 15 2 mod 4ð Þf gj j 5 2 mod 3ð Þf g½  mg=dð Þ
S4 ¼ 100 6 mod 13ð Þf g 15 3 mod 4ð Þf gj j 5 1 mod 3ð Þf g½  mg=dð Þ
S5 ¼ 100 3 mod 13ð Þf g 15 2 mod 4ð Þf gj j 5 0 mod 3ð Þf g½  mg=dð Þ
In this regard, these are Cartesian vectors accompanied with the dose unit ‘mg/d’; the
integers ‘xi’ following ‘mod’ are the divisors of the modulo operation (s mod x), which
yields the remainder after dividing s by x. The general form of the prescription vectors
is as follows:
Sj ¼ 100 s jð Þ1 mod 13ð Þ
 
15 s jð Þ2 mod 4ð Þ
   5 s jð Þ3 mod 3ð Þ
  
mg=dð Þ
where s(j)1, s(j)2, s(j)3 are positive integers and j = 1,2,. . .,n with n the total number of
sessions for patient observation. The (mg/d) following vector is the common unit for
all the components s(j)i in Sj; it is also permissible to have this unit included with the
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below.
We can confirm the ‘Sj’s also obey the group postulates because there is an identity
element ‘0’, and an inverse element of ‘s(j)i’ denoted ‘s(j)i
-1’ of the form ‘s(j)i
-1= xi - s(j)i’
for all components (‘xi’ being specifically x1= 13, x2= 4, x3= 3). By regarding ‘E = [100{0
(mod 13)}| 15{0 (mod 4)}| 5{0 (mod 3)}] (mg/d)’ as an identity element (no prescrip-
tion) and ‘Sj
-1= [100{s(j)1
-1 (mod 13)}| 15{s(j)2
-1 (mod 4)}| 5{s(j)3
-1 (mod 3)}] (mg/d) =
[100{x1 - s(j)1 (mod 13)}| 15{x2 - s(j)2 (mod 4)}| 5{x3 - s(j)3 (mod 3)}] (mg/d)’ as the in-
verse element of Sj, we can compose group S = {Sj (j = 1,. . .,WS)| Sj ∈ Z13×Z4×Z3}, the
set of all possible prescriptions consisting of the three specified drugs. In this regard, |
S| (the order of group S) is |S|≡13×4×3, The group composition law, denoted by ‘*’, is
modulo addition for each modulo group Zm, the set {0, 1, 2,. . ., m - 1} with ‘m’ a posi-
tive integer (Cayley tables are shown in Figures 1, 2). Note that group S contains the
non-prime modulo group Z4. Because inverses are non-unique for modulo groups
based on non-primes, such Zm cannot be develop into algebraic structures called rings
or fields. In this respect, S is limited to just modulo addition (and subtraction). In such
instances, there might be a loss in potential applicability in a more general
systematization available with matrices.
Following our previous report, we construct a transition operator S(j→k) that, when given
state Sj, outputs state Sk by acting on state Sj. This is defined as S(j→k) ≡ Sj
-1*Sk =Sk - Sj and
is seen as a difference between the two states Sj and Sk. For various elements Sj of S, we
present explicit expressions for possible transition operators (see Appendix A for details).
S 1→2ð Þ ¼ 100 2 mod 13ð Þf g 15 1 mod 4ð Þf gj j 5 1 mod 3ð Þf g½  mg=dð Þ
S 2→3ð Þ ¼ 100 2 mod 13ð Þf g 15 1 mod 4ð Þf gj j 5 1 mod 3ð Þf g½  mg=dð Þ
S 3→4ð Þ ¼ 100 2 mod 13ð Þf g 15 1 mod 4ð Þf gj j 5 2 mod 3ð Þf g½  mg=dð Þ
S 4→5ð Þ ¼ 100 10 mod 13ð Þf g 15 3 mod 4ð Þf gj j 5 2 mod 3ð Þf g½  mg=dð Þ0 0 100 200 300 400 500 600 700 800 900 1000 1100 1200
100 100 200 300 400 500 600 700 800 900 1000 1100 1200 0
200 200 300 400 500 600 700 800 900 1000 1100 1200 0 100
300 300 400 500 600 700 800 900 1000 1100 1200 0 100 200
400 400 500 600 700 800 900 1000 1100 1200 0 100 200 300
500 500 600 700 800 900 1000 1100 1200 0 100 200 300 400
600 600 700 800 900 1000 1100 1200 0 100 200 300 400 500
700 700 800 900 1000 1100 1200 0 100 200 300 400 500 600
800 800 900 1000 1100 1200 0 100 200 300 400 500 600 700
900 900 1000 1100 1200 0 100 200 300 400 500 600 700 800
1000 1000 1100 1200 0 100 200 300 400 500 600 700 800 900
1100 1100 1200 0 100 200 300 400 500 600 700 800 900 1000
1200 1200 0 100 200 300 400 500 600 700 800 900 1000 1100
0 100 200 300 400 500 600 700 800 900 1000 1100 1200
Lithium carbonate
Figure 1 Cayley table for dosages (mg/d) of ‘lithium carbonate’. When divided by 100 (the unit dose
of ‘lithium carbonate’), the numbers represent elements of C13={0,1,2,3,. . .,11,12} with modulo 13 addition.
Mirtazapine Nitrazepam
0 15 30 45
0 0 15 30 45
15 15 30 45 0
30 30 45 0 15
45 45 0 15 30
0 5 10
0 0 5 10
5 5 10 0
10 10 0 5
Figure 2 Cayley tables for dosages (mg/d) of ‘mirtazapine’ and ‘nitrazepam’. For the left table,
numbers represent elements of C4={0,1,2,3} with modulo 4 addition when divided by 15 (the unit dose of
‘mirtazapine’). Similarly, for the right table, when divided by 5 (the unit dose of ‘nitrazepam’) the numbers
represent elements of C3={0,1,2} with modulo 3 addition.
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states (see Appendix B for details). Thus, we can verify the transition
S1S 1→2ð ÞS 2→3ð ÞS 3→4ð ÞS 4→5ð Þ
¼ S1 þ S 1→2ð Þ þ S 2→3ð Þ þ S 3→4ð Þ þ S 4→5ð Þ
¼ 100 3 mod 13ð Þf g 15 2 mod 4ð Þf gj j 5 0 mod 3ð Þf g½  mg=dð Þ
¼ 300 mg=dð Þ 30 mg=dð Þj j 0 mg=dð Þ½ 
¼ S5:
Note, operator compositions follow the ‘right translation’ rule, that is the operatoracts from the right side of the state, Sj*S(j→k) = Sk. The preceding results indicate that
drug prescriptions might also be amenable as group-theoretical operations within a sin-
gle group S comprising all possible prescription combinations of three distinct but spe-
cified drugs.
In this way, not only multiple medical prescriptions, but other clinical data can also
be treated in a similar style. Although regarding patient states as vectors may be pecu-
liar from a meaningful pathological perspective, we believe that the way to use the pro-
posed model might indicate further potential approaches to handling various clinical
results. Specifically, we consider transitions in blood concentration of lithium carbonate
([Li+]), white blood cell (WBC), percutaneous oxygen saturation (SpO2), and systolic
blood pressure (SBP), as listed in Table 2. The only necessary condition is that these
results are non-negative real numbers with the inclusion of ‘0’. The order of each mod-
ulo group needs to be pre-defined so that it corresponds to maximum values. The
vectors of the state presented in Table 2 can be expressed using the appropriate modulo
additions. The order of the clinical values is as follows:
T ¼ Liþ½  mEq=lð Þ½ j WBC =mm3  j SpO2 %ð Þ j SBP mmHgð Þ and
T1 ¼ 0 mEq=lð Þ½ j 4000 =mm3
 j 98 %ð Þ j 120 mmHgð Þ:
Table 2 An example of a transition of various clinical values
Session 1 Session 2 Session 3 Session 4
[Li+] 0 mEq/l 0.10 mEq/l 0.15 mEq/l 0.51 mEq/l
WBC 4000/mm3 5400/mm3 12000/mm3 6500/mm3
SpO2 98% 82% 93% 99%
SBP 120 mmHg 145 mmHg 105 mmHg 95 mmHg
Abbreviations: [Li+], blood concentration of lithium carbonate; WBC, white blood cell; SpO2, percutaneous oxygen
saturation, and SBP: systolic blood pressure.
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T2 ¼ 0:10 mEq=lð Þ½ j 5400 =mm3
 j 82 %ð Þj 145 mmHgð Þ;
T3 ¼ 0:15 mEq=lð Þ½ j 12000 =mm3
 j 93 %ð Þj 105 mmHgð Þ; and
T4 ¼ 0:51 mEq=lð Þ½ j 6500 =mm3
 j 99 %ð Þj 95 mmHgð Þ:
By adding the respective units e.g., ‘(mEq/l)’ for each component of the ‘Tj’s, a moduloaddition format for the ‘Tj’s with the accompanying individual units is expressed as follows:
T1 ¼ 0:01 0 mod 600ð Þf g mEq=lð Þ½ j 4000 mod 50000ð Þ =mm3
 j 98 mod 100ð Þ
 %ð Þj 120 mod 300ð Þ mmHgð Þ;
T2 ¼ 0:01 10 mod 600ð Þf g mEq=lð Þ½ j 5400 mod 50000ð Þ =mm3
 j 82 mod 100ð Þ
 %ð Þj 145 mod 300ð Þ mmHgð Þ;
T3 ¼ 0:01 15 mod 600ð Þf g mEq=lð Þ½ j 12000 mod 50000ð Þ =mm3
 j 93 mod 100ð Þ
 %ð Þj 105 mod 300ð Þ mmHgð Þ; and
T4 ¼ 0:01 51 mod 600ð Þf g mEq=lð Þ½ j 6500 mod 50000ð Þ =mm3
 j 99 mod 100ð Þ
 %ð Þj 95 mod 300ð Þ mmHgÞð 
Similar to the ‘Sj’s,‘Tj’s also obey the group postulates so long as the components of Tj
reside in the pre-specified ranges. In other words, we have a group T= {Tj (j = 1,..., WT)|
Tj ∈ Z600×Z50000×Z100×Z300 }, the set of all possible data based on four distinct clinical
values. |T| (the order of group T) is |T|≡600×50000×100×300 (Cayley tables are shown in
Figures 3, 4, 5).
In a similar manner for S, the operators ‘ T(j→ k) ≡ Tj
− 1 * Tk = Tk −Tj ’ can be con-
structed (see Appendix C for details):
T 1→2ð Þ ¼ 0:01 10 mod 600ð Þf g mEq=lð Þ½ j 1400 mod 50000ð Þ =mm3
 j 84 mod 100ð Þ
 %ð Þj 25 mod 300ð Þ mmHgð Þ;
T 2→3ð Þ ¼ 0:01 5 mod 600ð Þf g mEq=lð Þ½ j 6600 mod 50000ð Þ =mm3
 j 11 mod 100ð Þ
 %ð Þj 260 mod 300ð Þ mmHgð Þ; and
T 3→4ð Þ ¼ 0:01 36 mod 600ð Þf g mEq=lð Þ½ j 44500 mod 50000ð Þ =mm3
 j 6 mod 100ð Þ
 %ð Þj 290 mod 300ð Þ mmHgð Þ
:
Also, transitions can naturally be traced iteratively (details given in Appendix D).
Thus
T1T 1→2ð ÞT 2→3ð ÞT 3→4ð Þ ¼ T1 þ T 1→2ð Þ þ T 2→3ð Þ þ T 3→4ð Þ
¼ 0:01 51 mod 600ð Þf g mEq=lð Þ½ j 6500 mod 50000ð Þ
 =mm3 j 99 mod 100ð Þ %ð Þj 95 mod 300ð Þ mmHgð Þ:
¼ 0:51 mEq=lð Þ½ j 6500 =mm3 j 99 %ð Þj 95 mmHgð Þ ¼ T4:
These results imply that medication levels and their changes can be composed as amodulo group, e.g., group S in the three-drug prescription (lithium carbonate,
0 0.01 0.02 0.03 …… 5.96 5.97 5.98 5.99
0 0 0.01 0.02 0.03 …… 5.96 5.97 5.98 5.99
0.01 0.01 0.02 0.03 0.04 …… 5.97 5.98 5.99 0
0.02 0.02 0.03 0.04 0.05 …… 5.98 5.99 0 0.01
0.03 0.03 0.04 0.05 0.06 …… 5.99 0 0.01 0.02
…… …… …… …… …… …… …… …… …… ……
5.96 5.96 5.97 5.98 5.99 …… 5.92 5.93 5.94 5.95
5.97 5.97 5.98 5.99 0 …… 5.93 5.94 5.95 5.96
5.98 5.98 5.99 0 0.01 …… 5.94 5.95 5.96 5.97
5.99 5.99 0 0.01 0.02 …… 5.95 5.96 5.97 5.98
Figure 3 Cayley table for [Li+]; blood concentration of ‘lithium carbonate’. Divided by 0.01, the
decimal numbers are associated with C600={0,1,2,3,. . .,598,599} satisfying modulo 600 addition.
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lithium carbonate ([Li+]), white blood cell (WBC), percutaneous oxygen saturation
(SpO2) and systolic blood pressure (SBP)) can also be expressed by a modulo group T.
Applications to the Tumor, Node, Metastasis (TNM) classification of malignant tumors
The TNM classification of malignant tumors, especially esophageal tumors, [8] forms
the basis of another application in line with this method. Esophageal tumors are classi-
fied according to the grade of severity: T (primary tumor), N (regional lymph nodes
metastasis), and M (distant metastasis). ‘T’ has subgrades from Tis (carcinoma in situ)
to T4 (adjacent structures), as in Figure 6; we have added ‘T0: Absent of histological
abnormality’. As depicted in Figure 6, we allocate scores from ‘0’ to some maximum to0 1 2 3 …… 49996 49997 49998 49999
0 0 1 2 3 …… 49996 49997 49998 49999
1 1 2 3 4 …… 49997 49998 49999 0
2 2 3 4 5 …… 49998 49999 0 1
3 3 4 5 6 …… 49999 0 1 2
…… …… …… …… …… …… …… …… …… ……
49996 49996 49997 49998 49999 …… 49992 49993 49994 49995
49997 49997 49998 49999 0 …… 49993 49994 49995 49996
49998 49998 49999 0 1 …… 49994 49995 49996 49997
49999 49999 0 1 2 …… 49995 49996 49997 49998
Figure 4 Cayley table for the modulo group C50000={0,1,2,3,. . .,49997,49998,49999} with modulo
50000 addition. Numbers representing the elements of the group are associated with white blood cell
(WBC) counts (per mm3).
0 1 2 3 … 96 97 98 99
0 0 1 2 3 … 96 97 98 99
1 1 2 3 4 … 97 98 99 0
2 2 3 4 5 … 98 99 0 1
3 3 4 5 6 … 99 0 1 2
… … … … … … … … … …
96 96 97 98 99 … 92 93 94 95
97 97 98 99 0 … 93 94 95 96
98 98 99 0 1 … 94 95 96 97
99 99 0 1 2 … 95 96 97 98
SpO2 SBP
0 1 2 3 … 296 297 298 299
0 0 1 2 3 … 296 297 298 299
1 1 2 3 4 … 297 298 299 0
2 2 3 4 5 … 298 299 0 1
3 3 4 5 6 … 299 0 1 2
… … … … … … … … … …
296 296 297 298 299 … 292 293 294 295
297 297 298 299 0 … 293 294 295 296
298 298 299 0 1 … 294 295 296 297
299 299 0 1 2 … 295 296 297 298
Figure 5 Cayley tables for percutaneous oxygen saturation (SpO2), and systolic blood pressure
(SBP). In the left table, the integers represent elements of C100={0,1,2,3,. . .,97,98,99} satisfying modulo 100
addition. Similarly, for the right table, the integers are associated with C300={0,1,2,3,. . .,297,298,299} with
modulo 300 addition.
Sawamura et al. Theoretical Biology and Medical Modelling 2012, 9:54 Page 8 of 19
http://www.tbiomed.com/content/9/1/54specify a sequential grading (right column). For ‘T’, we assign the integer values [T0: 0,
Tis: 1, T1a: 2, T1b: 3, T2: 4, T3: 5, T4a: 6, T4b: 7], and hence modulo 8 addition can be
defined. For ‘N’, we assign [N0: 0, N1: 1, N2: 2, N3: 3] with modulo 4 addition, and for
‘M’ defined in two ways as ‘Ma’ and ‘Mb’, for ‘M1a’ and ‘M1b’; [M0a: 0, M1a: 1], [M0b:
0, M1b: 1] with modulo 2 addition (In this regard, ‘Ma’ and ‘Mb’ are complementary,
one or other should be ‘0’). Based on these assignments, the following state vectors Cj
represent simple examples of a patient’s condition:
Cj ¼ ½T mod 8ð Þ N mod 4ð Þj jMa mod 2ð ÞjMb mod 2ð Þ;
C1 ¼ ½1 mod 8ð Þ 0 mod 4ð Þj j0 mod 2ð Þj0 mod 2ð Þ;
C2 ¼ ½3 mod 8ð Þ 1 mod 4ð Þj j0 mod 2ð Þj0 mod 2ð Þ;
C3 ¼ ½5 mod 8ð Þ 2 mod 4ð Þj j0 mod 2ð Þj1 mod 2ð Þ; and
C4 ¼ 4 mod 8ð Þ 3 mod 4ð Þj j0 mod 2ð Þj1 mod 2ð Þ:½
From these, transition operators producing changes in condition are defined next
(see Appendix E for details):
C 1→2ð Þ ¼ ½2 mod 8ð Þ 1 mod 4ð Þj j0 mod 2ð Þj0 mod 2ð Þ;
C 2→3ð Þ ¼ ½2 mod 8ð Þ 1 mod 4ð Þj j0 mod 2ð Þj1 mod 2ð Þ; and
C 3→4ð Þ ¼ ½7 mod 8ð Þ 1 mod 4ð Þj j0 mod 2ð Þj0 mod 2ð Þ:
Also, in a natural manner, a transitioning over the course of sessions can be estab-
lished iteratively. For example,C1C 1→2ð ÞC 2→3ð ÞC 3→4ð Þ ¼ C1 þ C 1→2ð Þ þ C 2→3ð Þ þ C 3→4ð Þ
N0: No regional lymph node metastasis
N1: 1 to 2 regional lymph nodes
N2: 3 to 6
N3: >6
[N1 was site dependent]
M0: No distant Metastasis
M1 Distant metastasis
[M1a,b were site dependent]
Changes from 6th edition
M1a:  
M1b:  
[Absent of histological abnormality]:
Tis: Carcinoma in situ /High-grade dysplasia
T1: lamina propria or submucosa
T1a: lamina propria or muscularis mucosae
T1b: submucosa
T2: muscularis propria
T3: adventitia
T4: adjacent structures
T4a: pleura, pericardium, diaphragm, 
or adjacent peritoneum
T4b: other adjacent structures,
e.g. aorta, vertebral body,
0
1
2
3
4
5
6
7
0
1
2
3
0
1
2
→
→
→
→
→
→
→
→
→
→
→
→
→
→
→
 
 *
 
* N1 was site dependent
m t t i
: Distant metastasis*
Changes from 6th dition
M1a:                              
b                               
* M1a,b were site dependent
/
 trachea
1→
Figure 6 Example of a modified Esophagus 7th edition, TNM definitions. A reclassification of
malignant tumors of the esophagus is presented. We have added a ‘T0’ entry. Then, the ‘T’ entries are
graduated over the range 0–7 (8 grades), ‘N’ over 0–3 (4 grades) and ‘M’ (defined in two ways, for ‘M1a’ and
‘M1b’) over 0–1 (2 grades). According to the number of respective criteria, modulo addition can be
introduced and a combination of modular groups, group C = {Cj | Cj ∈ Z8×Z4×Z2×Z2}, signifying that the
set of all composited histological disease states of malignant tumors is definable.
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http://www.tbiomed.com/content/9/1/54¼ 1 mod 8ð Þ 0 mod 4ð Þj j0 mod 2ð Þ 0 mod 2ð Þj ½
þ 2 mod 8ð Þ 1 mod 4ð Þj j0 mod 2ð Þ 0 mod 2ð Þj ½
þ 2 mod 8ð Þ 1 mod 4ð Þj j0 mod 2ð Þ 1 mod 2ð Þj ½
þ 7 mod 8ð Þ 1 mod 4ð Þj j0 mod 2ð Þ 0 mod 2ð Þj ½
¼ 1þ 2þ 2þ 7 mod 8ð Þ 0þ 1þ 1þ 1 mod 4ð Þj j0½
þ0þ 0þ 0 mod 2ð Þj0þ 0þ 1þ 0 mod 2ð Þ
¼ 12 mod 8ð Þ 3 mod 4ð Þj j0 mod 2ð Þ 1 mod 2ð Þj ½
¼ 4 mod 8ð Þ 3 mod 4ð Þj j0 mod 2ð Þ 1 mod 2ð Þj 
¼ C4:0 1 2 3 4 5 6 7
0 0 1 2 3 4 5 6 7
1 1 2 3 4 5 6 7 0
2 2 3 4 5 6 7 0 1
3 3 4 5 6 7 0 1 2
4 4 5 6 7 0 1 2 3
5 5 6 7 0 1 2 3 4
6 6 7 0 1 2 3 4 5
7 7 0 1 2 3 4 5 6
T (Primary Tumor)
Figure 7 Cayley table for T (primary tumor) graded according to scale 0–7 (8 grades).
N (Regional lymph nodes) Ma, Mb (Distant metastasis)
0 1 2 3
0 0 1 2 3
1 1 2 3 0
2 2 3 0 1
3 3 0 1 2
0 1
0 0 1
1 1 0
Figure 8 Cayley tables for N (regional lymph nodes) graded by scale 0–3 (4 grades), and M (distant
metastasis defined in two ways, for ‘M1a’ and ‘M1b’) graded by scale 0–1 (2 grades).
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within a single group C. In other words, we can define the group C = {Cj (j = 1,. . .,WC)| Cj
∈ Z8×Z4×Z2×Z2} as the set of all composable disease states in terms of tumor expansion
despite containing non-realistic elements such as [. . .|. . .|1 (mod 2)|1 (mod 2)]. In this
regard, |C| (the order of group C) is |C|≡ 8×4×2×2 (Cayley tables are presented in
Figures 7 and 8).
Applications to the International Statistical Classification of Diseases and Related Health
Problems (ICD)
In the same manner, using the coding schemes of the ICD, almost the same procedures
are evident. For instance, a vector-like description containing hypertension (HT), heart
failure (HF), diabetes mellitus (DM), panperitonitis, systemic lupus erythematosus
(SLE), panic disorder, C-reactive protein (CRP) can be described as follows: for each
disease sequential integer scores signify the relative severity with 0 (absence of abnor-
mal sign),. . .,3 (an average score),. . ., 6 (extremely severe). Naturally, inclusion of cer-
tain aspects of the disease, more detail about the symptomatic domain, and/or
laboratory data is possible under the condition that a rigorous ordering of all items can
be established that can be indexed from ‘1’, to ‘n’ with n the total number of diseases,
symptoms or laboratory data considered. Hence, with
Dj = [hypertension (mod 7)|heart failure (mod 7)|diabetes mellitus (mod 7)|panperitoni-
tis (mod 7)|systemic lupus erythematosus (mod 7)|panic disorder (mod 7)| C-reactive
protein (mg/l)], examples of possible states would be:
D1 ¼ 4 mod 7ð Þ½ j1 mod 7ð Þ 1 mod 7ð Þj j0 mod 7ð Þ 5 mod 7ð Þj j2 mod 7ð Þj4:5 mg=lð Þ;
D2 ¼ 3 mod 7ð Þ½ j3 mod 7ð Þ 2 mod 7ð Þj j1 mod 7ð Þ 6 mod 7ð Þj j1 mod 7ð Þj7:6 mg=lð Þ; and
D3 ¼ 4 mod 7ð Þ½ j1 mod 7ð Þ 3 mod 7ð Þj j0 mod 7ð Þ 4 mod 7ð Þj j0 mod 7ð Þj0:28 mg=lð Þ:
The last component (namely CRP) can be treated in modulo addition by devisingan integral expression with an appropriate determination of a modulo divisor so
that the maximum CRP would be set at, for example, ‘20 mg/l’ that is expected
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in the same way as ‘Sj’s, and ‘Tj’s, through the definition such as ‘D1 = [. . . |0.01
{450 (mod 2000)} (mg/l)], D2 = [. . . |0.01{760 (mod 2000)} (mg/l)], and D3 = [. . . |0.01
{28 (mod 2000)} (mg/l)] ’.
However, in this Dj format, a problem arises in that there is an instance of CRP exceed-
ing its assumed maximum value (‘2000’), that is ‘20 mg/l’. With such occurrences, the sim-
plicity of the model might be lost. Therefore, we choose an ordinal sequencing (e.g., ‘0−6’)
under the assumption that the grades are defined over intervals; e.g., the CRP scoring
ranges might be 0: 0.00−0.02, 1: 0.03−1.00, 2: 1.01−3.00, 3: 3.01−6.00, 4: 6.01−12.0,
5: 12.01−20.00, 6: ≥ 20.01 mg/l and we need to demonstrate that this is in line with proce-
dures. If adopted, D1 − D3 become:
D1 ¼ 4 mod 7ð Þ½ j1 mod 7ð Þ 1 mod 7ð Þj j0 mod 7ð Þ 5 mod 7ð Þj j2 mod 7ð Þj3 mod 7ð Þ
¼ 4 1j j1 0j j5 2j j3½  mod 7ð Þ;
D2 ¼ 3 mod 7ð Þ½ j3 mod 7ð Þ 2 mod 7ð Þj j1 mod 7ð Þ 6 mod 7ð Þj j1 mod 7ð Þj4 mod 7ð Þ
¼ 3 3j j2 1j j6 1j j4½  mod 7ð Þ; and
D3 ¼ 4 mod 7ð Þ½ j1 mod 7ð Þ 3 mod 7ð Þj j0 mod 7ð Þ 4 mod 7ð Þj j0 mod 7ð Þj1 mod 7ð Þ
¼ 4 1j j3 0j j4 0j j1½  mod 7ð Þ:
Transition operators generating the natural changes in state are defined as follows(see Appendix F for details):
D 1→2ð Þ ¼ 6 2j j1 1j j1 6j j1½  mod 7ð Þ and
D 2→3ð Þ ¼ 1 5j j1 6j j5 6j j4½  mod 7ð Þ
In the same fashion as ‘C(j→k)’s, sequential transitions over the course of sessions can
be performed iteratively (A demonstration is presented in Appendix G). Hence
D1  D 1→2ð Þ  D 2→3ð Þ ¼ D1 þ D 1→2ð Þ þ D 2→3ð Þ
¼ 4 1j j1 0j j5 2j j3½  mod 7ð Þ þ 6 2j j1 1j j1 6j j1½  mod 7ð Þ þ 1 5j j1 6j j5 6j j4½  mod 7ð Þ
¼ 4þ 6þ 1 1þ 2þ 5j j1þ 1þ 1 0þ 1þ 6j j5þ 1þ 5 2þ 6þ 6j j3þ 1þ 4½  mod 7ð Þ
¼ 11 8j j3 7j j11 14j j8½  mod 7ð Þ
¼ 4 1j j3 0j j4 0j j1½  mod 7ð Þ
¼ D3:
Therefore, the ICD coding schemes is also amenable to a modulo group formulation
which contain an operator subset that generates all possible transitions regardless of
disease severity and laboratory data. Here the group is D = {Dj (j = 1,. . .,WD)| Dj ∈
Z7×Z7×Z7×. . .×Z7 (n times)} the set of all possible combinations of severities among a
number n of diseases and laboratory data. In this regard, |D| (the order of group D) is
|D|≡ 7n (A Cayley table is presented in Figure 9).Discussion
In line with the model suggested in our previous article [5], we demonstrate further
possible applications using clinical quantities usually seen in daily clinical practices.
There, so long as ordinal numbers, including ‘0’ to represent the identity element under
modular arithmetic, can reflect the essential characteristics associated with the clinical
quantities an appropriately-sized modular group with modulo addition can be con-
structed. We envisage that if this kind of algorithm is established properly, we can not
0 1 2 3 4 5 6
0 0 1 2 3 4 5 6
1 1 2 3 4 5 6 0
2 2 3 4 5 6 0 1
3 3 4 5 6 0 1 2
4 4 5 6 0 1 2 3
5 5 6 0 1 2 3 4
6 6 0 1 2 3 4 5
ICD
Figure 9 Cayley table for modulo group C7 with 7 elements for the International Statistical
Classification of Diseases and Related Health Problems (ICD).
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but also open a door to establish a more refined, sophisticated systematization of
clinical medicine, and reduce the futility in the current descriptive style of medi-
cine mentioned in our previous report. The global landscape is ambiguous at the
present stage; a more simple and rational landscape might exist by constructing an
ideal style based on group-theoretical concepts. However, this is only a presump-
tive half step but one we believe would be a break-through servicing future medi-
cine. Moreover, we also believe unknown advantages exist in the handling and
monitoring of clinical values of patients.
The model proposed is far from complete and there are major restrictions and diffi-
culties in applying it immediately in clinical treatment. Therefore, those limitations of
our proposal should be noted here. First, it is doubtful that grading medicine dosage
(or various clinical quantities) is appropriate; whether the assumption that dosage levels
have the same step-wise increments is suitable to apply in all instances requires asses-
sing. One of the merits of the proposed model is that we can treat clinical values using
a single group regardless whether the clinical values are absolute quantities or not
(there might be relative differences among various states containing treatment as an
operator). This confusion might generate considerable futilities and/or disadvantages in
the data. This is a crucially unavoidable issue that needs to be examined thoroughly
through rigorous methodology.
Second, the value of the divisor ‘xi’ that defines the modulo operation is not always
suitable because those values dealt with in this article have not always been optimal.
For instance, if the WBC is ‘55000/mm3’ under modulo 50000 addition this becomes
5000, which has little significance in our clinical experiences. This problem can be
avoided if we select a larger divisor, say xi = 60000. However, coping with the problem
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might occur in not only WBC data but also [Li+] and SBP (mmHg) as well as clinical
examination data. Furthermore, if we avoid this problem by taking sufficiently large
divisors, then this yields another type of problem; the modular inverse of certain values
can yield large values. For example, under modulo 200000 addition and a WBC value
of 12000, the inverse of 12000 is then ‘188000 (= 200000–12000)’. Such values might
be too large to be treated in ordinal order when used as a laboratory result. To con-
struct the most convenient model, divisors should be optimized to suitable values that
yield more appropriate clinical data. Optionally, indexed descriptions, for instance,
might be possible; WBC values of ‘75000’ under modulo 20000 addition are expressed
as ‘75000 = 20000×3 + 15000 = 150003 (mod 20000)’, although the index number (viz.,
subscript ‘3’) is only a mark, and ‘150003’ should be treated as merely the element
‘15000’ in modulo group C20000. Alternatively, if we decide to focus on the specific
range of objects, it might be better to use a common value, such as WBC = 20000, and
ignore data values exceeding it; by ignoring large numbers, we can focus instead on the
modular set, which in so doing might actually provide advantages in data assessment.
Thus, advantages and disadvantages arise together.
Similarly, a large divisor would also be problematic in prescribing medicines such as
mirtazapine. Some psychiatrists might medicate mirtazapine over the ordinal-assumed
maximum dose, e.g., 45 mg/d. In that instances, we cannot prescribe a mirtazapine
dose of 60 mg/d in modulo 4 addition from 15·{0, 1, 2 or 3} mg/d. By raising the max-
imum dose from 45 to 60 mg/d, we can avoid such issues, noting though that there
may be a need for treatments outside the stipulated range. Moreover, transitions asso-
ciated with ‘highest dosage state back to lowest’ and ‘high-grade tumor to tumor free’
resulting from the maximum grade being changed into the minimum grade’ might be-
come an departure from our clinical experiences. Here, we have only exploited cyclic
groups Z and held that the results should be interpreted as if these were a linear meas-
ure limited within a finite range (less than the order of Z) even when the results of
operations exceed the order of Z. However, medical data, such as those treated in the
present article, could be treated not by cyclic Z groups, as for instance ‘S’ and ‘T’, but
rather by some structure that may better reflect clinical expectations like groupoids
where only the closure law is postulated. From this standpoint, the more suitable
aspects that are less likely to produce paradoxes may be those exemplified by ‘Cj’s and
‘Dj’s where only a finite grading, ‘0–6’, arises. For these reasons, more effective schemes
need to be developed in future studies.
Third, it is always possible to combine any two vectors based on this model; e.g., Sj
and Tj can be combined into a unique vector respecting the definition of each individ-
ual component, e.g., Uj = [Sj|Tj] = [100{3 (mod 13)} (mg/d)| 15{2 (mod 4)} (mg/d)|5{0
(mod 3)} (mg/d)| 0.01{10 (mod 600)} (mEq/l)| 5400 (50000) (/mm3)| 82 (mod 100)
(%)| 145 (mod 300) (mmHg)]. Thus, peculiar combinations of the data sets are likely
to occur. For example, the above Cartesian vector Uj has a clear mathematical basis
but Sj and Tj might have in combination little direct clinical connections. In other
words, large vectors might contain many trivial, similar, redundant and unrelated
items which become less meaningful in terms of a clinical standpoint. This is crucially
antithetical to the intention of our model and a truly reasonable methodology is neces-
sary to cope with this issue.
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instead just natural numbers for graded scoring, e.g., ‘0–6’, or replacing negative quan-
tities with its inverse. Coping with the latter might yield distortions in the data. Basic-
ally, the model becomes more useful when it treats: 1) the concentrations of substances
that deviate from normal human body levels as ordinal states (for example medicine or
specific immuno-antibodies) unless strict limits in their use (such as administration)
are determined; and 2) the cases where the grades of severity (not the degree of well-
ness of body and mind) include the ‘0’ state as an absence of abnormal data/signs (the
presence of a normal state), and those that are non-gradable meaning worse states
above the pre-determined maximum number (for example ‘6’). The conversion between
row data and graded scorings is in general effective with data based on positive num-
bers. This lack of symmetry in data with respect to positive and negative numbers is a
problem that should be resolvable under a rigorous methodology.
Fifth, although in our previous models the ideally healthy state of persons is
expressed as an identity element ‘E’, represented by ‘grade 0’, in the present article, ‘0’ is
genuinely interpreted as a zero (whatever the unit accompanying it) that produces
according to modulo additions no change when acting on other data component.
Therefore, in a more expansive sense, ‘0’ may not always signify the most desired state
of the laboratory data set (e.g., in the case of Tj). Of course, among vectors representing
disease severity, the ideally desirable (healthy) state is ‘E = [0|0|0|. . .|0]’; however, this
postulate is met in Sj, as well as Cj and Dj, through strict definition. As for other appli-
cations such as medication, blood concentration of medicine (e.g.,[Li+]), and WBC,
even if the scores are graded in ‘0–6’, ‘grade 0’ does not always represent the healthy
state. The regular (standard) ranges of various laboratory quantities usually exist, and
these are the truly desirable proportions of clinical values. We should keep in mind
such differences in interpretations of ‘0’s.
Sixth, of the various types of modulo operation, only modulo addition has been used
in the present article. One of the reasons is the number of grades is not always a prime
number, although the modulo operation based on a prime is convenient in modeling
[10,11]. Modulo groups based on prime numbers ensure existence of a unique inverse
element, without which the possibility of extending the model to ‘rings’ and ‘fields’ is
lost. If in the future our models were to be represented in matrix form, this lack of
uniqueness might become a considerable disadvantage, for instance, when using
inverses of matrices. Although in this model clinical data might not always have a
genuine realization by groups, rings, or fields (semi-groups were mentioned in our pre-
vious report as a possibility), it can be advantageous to construct a realization that
obeys ring or field axioms, even if artificially. Thus, a fundamental resolution of this
problem is desired.
Seventh, the present model records and describes each patient’s data set retrospect-
ively. Needless to say, the most valuable information in science is that which is predict-
ive either quantitatively or qualitatively following empirical rules. This model is not
considered effective in performing such predictions, at least, in the present form. Per-
haps by adding standard deviations ‘±S.D.’ to averages of each data component, trends
in scores could then be overviewed given that sufficient data are recorded with the
stipulation that each ‘S.D.’ is defined for various types of component combinations at
various sessions. For these reasons, future studies are necessary.
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ical quantities as vectors, i.e., independent products of severity levels and/or labora-
tory quantities, might not always best describe the total disease state. From another
perspective, the total disease state is not always composed as a Cartesian vector com-
prising the respective symptoms and/or individual laboratory data. A total state is not
always the product of its partial components, so, the Cartesian vector expression
might serve initially to describe and record each clinical quantity independently, but
subsequent unexpected connections and/or biases can undermine our simple analysis
or obscure links that might exist among individual components. In the kind of model
based on linear relationships that we have described, this is a crucial issue to treat.
However, as was mentioned in our previous report, we emphasize that to encapsulate
the descriptive style of medicine by group postulates is underscored by the fact that
behaviors of certain models can be treated generally and unexceptionally so that genuine
mathematical methods can be performed on such models. Therefore, we desire that fu-
ture studies of such issues can be explored in more effective forms. Examples illustrated
in this article hopefully provide further understanding for readers of the model so that
for future development more rigorous investigations can be conducted where more gen-
eralized operations can effect a significant contribution.Conclusions
Within the limited scope of our methodology, there are grounds where other clinical
quantities (prescription of medicine, laboratory data, TNM classification of malignant
tumors, and ICD coding schemes) can be also treatable with the same group-theory
approach as was suggested for psychiatric disease states in our previous report.Appendices
In the following appendices A–G, we provide explicit calculations of various operations
using the modulo groups S, T, C, and D to be found in the text.Appendix AS 1→2ð Þ ¼ S2  S1¼ 100 2 mod 13ð Þf g 15 1 mod 4ð Þf gj j 5 1 mod 3ð Þf g½  mg=dð Þ
 100 0 mod 13ð Þf g 15 0 mod 4ð Þf gj j 5 0 mod 3ð Þf g½  mg=dð Þ
¼ 100 2–0 mod 13ð Þf g 15 1–0 mod 4ð Þf gj j 5 1–0 mod 3ð Þf g½  mg=dð Þ
¼ 100 2 mod 13ð Þf g 15 1 mod 4ð Þf gj j 5 1 mod 3ð Þf g½  mg=dð ÞS 2→3ð Þ ¼ S3  S2¼ 100 4 mod 13ð Þf g 15 2 mod 4ð Þf gj j 5 2 mod 3ð Þf g½  mg=dð Þ
 100 2 mod 13ð Þf g 15 1 mod 4ð Þf gj j 5 1 mod 3ð Þf g½  mg=dð Þ
¼ 100 4–2 mod 13ð Þf g 15 2–1 mod 4ð Þf gj j 5 2–1 mod 3ð Þf g½  mg=dð Þ
¼ 100 2 mod 13ð Þf g 15 1 mod 4ð Þf gj j 5 1 mod 3ð Þf g½  mg=dð Þ
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¼ 100 6 mod 13ð Þf g 15 3 mod 4ð Þf gj j 5 1 mod 3ð Þf g½  mg=dð Þ
 100 4 mod 13ð Þf g 15 2 mod 4ð Þf gj j 5 2 mod 3ð Þf g½  mg=dð Þ
¼ 100 6–4 mod 13ð Þf g 15 3–2 mod 4ð Þf gj j 5 1–2 mod 3ð Þf g½  mg=dð Þ
¼ 100 2 mod 13ð Þf g 15 1 mod 4ð Þf gj j 5 1 mod 3ð Þf g½  mg=dð Þ
¼ 100 2 mod 13ð Þf g 15 1 mod 4ð Þf gj j 5 2 ¼ 1þ 3ð Þ mod 3ð Þf g½  mg=dð Þ
S 4→5ð Þ ¼ S5  S4
¼ 100 3 mod 13ð Þf g 15 2 mod 4ð Þf gj j 5 0 mod 3ð Þf g½  mg=dð Þ
 100 6 mod 13ð Þf g 15 3 mod 4ð Þf gj j 5 1 mod 3ð Þf g½  mg=dð Þ
¼ 100 3–6 mod 13ð Þf g 15 2–3 mod 4ð Þf gj j 5 0–1 mod 3ð Þf g½  mg=dð Þ
¼ 100 3 mod 13ð Þf g 15 1 mod 4ð Þf gj j 5 1 mod 3ð Þf g½  mg=dð Þ
¼ 100 10 ¼ 3þ 13ð Þ mod 13ð Þf g 15 3 ¼ 1þ 4ð Þ mod 4ð Þf gj j½
5 2 ¼ 1þ 3ð Þ mod 3ð Þf g mg=dð Þ:
Appendix B
S1S 1→2ð ÞS 2→3ð ÞS 3→4ð ÞS 4→5ð Þ
¼ S1 þ S 1→2ð Þ þ S 2→3ð Þ þ S 3→4ð Þ þ S 4→5ð Þ
¼ 100 0 mod 13ð Þf g 15 0 mod 4ð Þf gj j 5 0 mod 3ð Þf g½  mg=dð Þ
þ 100 2 mod 13ð Þf g 15 1 mod 4ð Þf gj j 5 1 mod 3ð Þf g½  mg=dð Þ
þ 100 2 mod 13ð Þf g 15 1 mod 4ð Þf gj j 5 1 mod 3ð Þf g½  mg=dð Þ
þ 100 2 mod 13ð Þf g 15 1 mod 4ð Þf gj j 5 2 mod 3ð Þf g½  mg=dð Þ
þ 100 10 mod 13ð Þf g 15 3 mod 4ð Þf gj j 5 2 mod 3ð Þf g½  mg=dð Þ
¼ 100 0þ 2þ 2þ 2þ 10 mod 13ð Þf g 15 0þ 1þ 1þ 1þ 3 mod 4ð Þf gj j½
5 0þ 1þ 1þ 2þ 2 mod 3ð Þf g mg=dð Þ
¼ 100 16 mod 13ð Þf g 15 6 mod 4ð Þf gj j 5 6 mod 3ð Þf g½  mg=dð Þ
¼ 100 3 mod 13ð Þf g 15 2 mod 4ð Þf gj j 5 0 mod 3ð Þf g½  mg=dð Þ
¼ 300 mg=dð Þ 30 mg=dð Þj j 0 mg=dð Þ½ :
Appendix C
T 1→2ð Þ ¼ T2  T1
¼ 0:01 10 mod 600ð Þf g mEq=lð Þ½ j 5400 mod 50000ð Þ =mm3 j
82 mod 100ð Þ %ð Þj 145 mod 300ð Þ mmHgð Þ
 0:01 0 mod 600ð Þf g mEq=lð Þ½ j 4000 mod 50000ð Þ =mm3 j
98 mod 100ð Þ %ð Þj 120 mod 300ð Þ mmHgð Þ
¼ 0:01 10–0 mod 600ð Þf g mEq=lð Þ½ j5400–4000 mod 50000ð Þ =mm3 j
82–98 mod 100ð Þ %ð Þj145–120 mod 300ð Þ mmHgð Þ
¼ 0:01 10 mod 600ð Þf g mEq=lð Þ½ j 1400 mod 50000ð Þ =mm3 j
16 mod 100ð Þ %ð Þj 25 mod 300ð Þ mmHgð Þ
¼ 0:01 10 mod 600ð Þf g mEq=lð Þ½ j 1400 mod 50000ð Þ =mm3 j 84 ¼ 16þ 100ð Þ
mod 100ð Þ %ð Þj 25 mod 300ð Þ mmHgð Þ
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http://www.tbiomed.com/content/9/1/54T 2→3ð Þ ¼ T3  T2¼ 0:01 15 mod 600ð Þf g mEq=lð Þ½ j 12000 mod 50000ð Þ =mm3 j
93 mod 100ð Þ %ð Þj 105 mod 300ð Þ mmHgð Þ
 0:01 10 mod 600ð Þf g mEq=lð Þ½ j 5400 mod 50000ð Þ =mm3 j
82 mod 100ð Þ %ð Þj 145 mod 300ð Þ mmHgð Þ
¼ 0:01 15–10 mod 600ð Þf g mEq=lð Þ½ j12000–5400 mod 50000ð Þ
=mm3
 93–82 mod 100ð Þ %ð Þj105–145 mod 300ð Þ mmHgð Þ
¼ 0:01 5 mod 600ð Þf g mEq=lð Þ½ j 6600 mod 50000ð Þ =mm3 j 11 mod 100ð Þ %ð Þj
40 mod 300ð Þ mmHgð Þ
¼ 0:01 5 mod 600ð Þf g mEq=lð Þ½ j 6600 mod 50000ð Þ =mm3 j
11 mod 100ð Þ %ð Þj 260 ¼ 40þ 300ð Þ mod 300ð Þ mmHgð Þ
T 3→4ð Þ ¼ T4  T3
¼ 0:01 51 mod 600ð Þf g mEq=lð Þ½ j 6500 mod 50000ð Þ =mm3 j
99 mod 100ð Þ %ð Þj 95 mod 300ð Þ mmHgð Þ  ½0:01 15 mod 600ð Þf g
mEq=lð Þj 12000 mod 50000ð Þ =mm3 j 93 mod 100ð Þ %ð Þj
105 mod 300ð Þ mmHgð Þ
¼ 0:01 51–15 mod 600ð Þf g mEq=lð Þ½ j6500–12000 mod 50000ð Þ =mm3 j
99–93 mod 100ð Þ %ð Þj95–105 mod 300ð Þ mmHgð Þ
¼ 0:01 36 mod 600ð Þf g mEq=lð Þ½ j  5500 mod 50000ð Þ =mm3 j 6 mod 100ð Þ %ð Þj
10 mod 300ð Þ mmHgð Þ
¼ 0:01 36 mod 600ð Þf g mEq=lð Þ½ j44500 ¼ 5500þ 50000ð Þ mod 50000ð Þ =mm3 j
6 mod 100ð Þ %ð Þj 290 ¼ 10þ 300ð Þ mod 300ð Þ mmHgð Þ:
Appendix D
T1T 1→2ð ÞT 2→3ð ÞT 3→4ð Þ
¼ T1 þ T 1→2ð Þ þ T 2→3ð Þ þ T 3→4ð Þ
¼ 0:01 0 mod 600ð Þf g mEq=lð Þ½ j 4000 mod 50000ð Þ =mm3 j
98 mod 100ð Þ %ð Þj 120 mod 300ð Þ mmHgð Þ
þ 0:01 10 mod 600ð Þf g mEq=lð Þ½ j 1400 mod 50000ð Þ =mm3 j
84 mod 100ð Þ %ð Þj 25 mod 300ð Þ mmHgð Þ
þ 0:01 5 mod 600ð Þf g mEq=lð Þ½ j 6600 mod 50000ð Þ =mm3 j
11 mod 100ð Þ %ð Þj 260 mod 300ð Þ mmHgð Þ
þ 0:01 36 mod 600ð Þf g mEq=lð Þ½ j 44500 mod 50000ð Þ =mm3 j
6 mod 100ð Þ %ð Þj 290 mod 300ð Þ mmHgð Þ
¼ ½0:01 0þ 10þ 5þ 36 mod 600ð Þf g
mEq=lð Þj 4000þ 1400þ 6600þ 44500 mod 50000ð Þ =mm3 j 98
þ 84 þ 11 þ 6 mod 100ð Þ %ð Þj 120þ 25 þ 260þ 290 mod 300ð Þ mmHgð Þ
¼ 0:01 51 mod 600ð Þf g mEq=lð Þ½ j 56500 mod 50000ð Þ =mm3 j
199 mod 100ð Þ %ð Þj 695 mod 300ð Þ mmHgð Þ
¼ 0:01 51 mod 600ð Þf g mEq=lð Þ½ j56500–50000 mod 50000ð Þ
=mm3
 j199–100 mod 100ð Þ %ð Þj 695  300 2 mod 300ð Þ mmHgð Þ
¼ 0:01 51 mod 600ð Þf g mEq=lð Þ½ j 6500 mod 50000ð Þ =mm3 j 99 mod 100ð Þ
%ð Þj 95 mod 300ð Þ mmHgð Þ:
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C 1→2ð Þ ¼ C2  C1 ¼ 3 mod 8ð Þ 1 mod 4ð Þj j0 mod 2ð Þ 0 mod 2ð Þj ½
 1 mod 8ð Þ 0 mod 4ð Þj j0 mod 2ð Þ 0 mod 2ð Þj ½
¼ 3–1 mod 8ð Þ 1 0 mod 4ð Þj j0 0 mod 2ð Þ½ j0 0 mod 2ð Þ
¼ 2 mod 8ð Þ 1 mod 4ð Þj j0 mod 2ð Þ 0 modð Þj ½
C 2→3ð Þ ¼ C3  C2 ¼ 5 mod 8ð Þ 2 mod 4ð Þj j0 mod 2ð Þ 1 mod 2ð Þj ½
 3 mod 8ð Þ 1 mod 4ð Þj j0 mod 2ð Þ 0 mod 2ð Þj ½
¼ 5–3 mod 8ð Þ 2 1 mod 4ð Þj j0 0 mod 2ð Þ½ j1  0 mod 2ð Þ
¼ 2 mod 8ð Þ 1 mod 4ð Þj j0 mod 2ð Þ 1 modð Þj ½
C 3→4ð Þ ¼ C4  C3 ¼ 4 mod 8ð Þ 3 mod 4ð Þj j0 mod 2ð Þ 1 mod 2ð Þj ½
 5 mod 8ð Þ 2 mod 4ð Þj j0 mod 2ð Þ 1 mod 2ð Þj ½
¼ 4–5 mod 8ð Þ 3 2 mod 4ð Þj j0 0 mod 2ð Þ½ j1  1 mod 2ð Þ
¼ 1 mod 8ð Þ 1 mod 4ð Þj j0 mod 2ð Þ½ j0 mod 2ð Þ
¼ 7 mod 8ð Þ 1 mod 4ð Þj j0 mod 2ð Þ 0 mod 2ð Þj :½
Appendix F
D 1→2ð Þ ¼ D2  D1
¼ 3 4 3 1j j2 1 1 0j j6 5 1 2j j4 3½  mod 7ð Þ
¼ 1 2j j1 1j j1 1j j1½  mod 7ð Þ
¼ 6 2j j1 1j j1 6j j1½  mod 7ð Þ
D 2→3ð Þ ¼ D3  D2
¼ 4 3 1 3j j3 2 0 1j j4 6 0 1j j1 4½  mod 7ð Þ
¼ 1 2j j1 1j j  2 1j j  3½  mod 7ð Þ
¼ 1 5j j1 6j j5 6j j4½  mod 7ð Þ:
Appendix G
D1D 1→2ð ÞD 2→3ð Þ
¼ D1 þ D 1→2ð Þ þ D 2→3ð Þ
¼ 4 1j j1 0j j5 2j j3½  mod 7ð Þ
þ 6 2j j1 1j j1 6j j1½  mod 7ð Þ
þ 1 5j j1 6j j5 6j j4½  mod 7ð Þ
¼ 4þ 6þ 1 1þ 2þ 5j j1þ 1þ 1 0þ 1þ 6j j5þ 1þ 5 2þ 6þ 6j j3þ 1þ 4½  mod 7ð Þ
¼ 11 8j j3 7j j11 14j j8½  mod 7ð Þ
¼ 4 1j j3 0j j4 0j j1½  mod 7ð Þ:
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